Licensed pharmaceutical wholesaler and exporter in India New Delhi · Mumbai[email protected]
Buyer guide

Named Patient Supply and Special Access Explained

When a medicine is not registered in a country, several regulators allow it to be obtained for an individual patient. The names differ, the idea is the same.

Bio Bridge Pharma · Updated 16 November 2026 · Based on official sources listed below

What named patient supply means

Named patient supply, also called special access or compassionate supply, is a route for a medicine that is not registered in a country to reach a specific patient. The request normally comes from the treating practitioner or a licensed healthcare institution, and the regulator sets the conditions.

The three examples below show how much the details vary, so always check the rules of your own country.

Canada: Special Access Program

  • Health Canada's Special Access Program lets practitioners request a drug that is unavailable for sale in Canada.
  • Most often the practitioner using the programme is a licensed physician.
  • It is intended for patients with serious or life-threatening conditions where conventional treatments have failed, are unsuitable or are unavailable.

Singapore: Special Access Routes

  • The Health Sciences Authority allows unregistered therapeutic products to be imported for patients through its special access routes.
  • Applications can come from a licensed hospital, clinic or nursing home, from a retail pharmacy with a valid prescription from a registered doctor or dentist, or from a company acting on behalf of a licensed hospital, clinic or nursing home.
  • HSA says unregistered products should only be considered for life-saving therapies, and approval is needed for each consignment before import.
  • The importer needs an importer's licence and a wholesaler's licence from HSA before importing, and the requesting doctor or dentist is fully responsible for the use of the product.

New Zealand: section 29 of the Medicines Act 1981

  • Section 29 permits the supply of unapproved medicines to medical practitioners, nurse practitioners and pharmacist prescribers.
  • Supply is for the treatment of a named patient under their care.
  • Suppliers notify Medsafe after the end of every month in which the medicine was supplied.

What these routes have in common

  • One patient at a time. Supply is linked to an individual patient and a responsible practitioner or institution.
  • The regulator decides. An approval, a notification or both may be needed, sometimes for each consignment.
  • Licensed importers. The organisation bringing the medicine into the country may need its own licences.

What to have ready

  • The medicine: INN or brand, strength, dosage form and pack size
  • The quantity needed for the patient
  • The destination country and the importing organisation
  • Any approval or reference your regulator has issued
How Bio Bridge Pharma helps

We supply medicines for named patients where the destination country's rules allow it. See Named Patient Supply or send your enquiry.

Send Enquiry

Sources

  1. Health Canada, Special Access Program for drugs: canada.ca
  2. Health Sciences Authority, Singapore, import for patients (special access routes): hsa.gov.sg
  3. Medsafe, New Zealand, use of unapproved medicines: medsafe.govt.nz
Enquiries

Need a medicine supplied outside India?

Send the product, strength and destination country. We confirm the registration route and import licence for that destination, then send our offer.

Send Enquiry